Proresolution lipid mediators in multiple sclerosis - differential, disease severity-dependent synthesis - a clinical pilot trial (Q34586379)

3 August 2017

title

Proresolution lipid mediators in multiple sclerosis - differential, disease severity-dependent synthesis - a clinical pilot trial (English)

1 reference

3 August 2017

0 references

4

Benedikt Brommer

0 references

author name string

Harald Prüss

1

1 reference

3 August 2017

Berit Rosche

2

1 reference

3 August 2017

Aaron B Sullivan

3

1 reference

3 August 2017

Benedikt Brommer

4

1 reference

3 August 2017

Oliver Wengert

5

1 reference

3 August 2017

Karsten Gronert

6

1 reference

3 August 2017

Jan M Schwab

7

1 reference

3 August 2017

language of work or name

English

0 references

publication date

8 February 2013

1 reference

3 August 2017

1 reference

3 August 2017

volume

8

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

e55859

1 reference

Creative Commons Attribution 4.0 International

3 August 2017

copyright license

start time

8 February 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Rapid induction of inflammatory lipid mediators by the inflammasome in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568070

12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568070

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568070

5-Lipoxygenase metabolite 4-HDHA is a mediator of the antiangiogenic effect of ω-3 polyunsaturated fatty acids

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568070

Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568070

Nonresolving inflammation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568070

Endogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568070

Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568070

Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568070

Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568070

Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568070

Resolvin E1 and protectin D1 activate inflammation-resolution programmes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568070

Resolution of inflammation: the beginning programs the end

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568070

Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568070

Inflammatory resolution: new opportunities for drug discovery

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568070

Acute changes in dietary omega-3 and omega-6 polyunsaturated fatty acids have a pronounced impact on survival following ischemic renal injury and formation of renoprotective docosahexaenoic acid-derived protectin D1.

7 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055859

Lipid mediator class switching during acute inflammation: signals in resolution.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055859

Cerebrospinal fluid isoprostane shows oxidative stress in patients with multiple sclerosis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23409068

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23409068

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PONE.0055859

1 reference

release_fwrxp3ntezg3dbxpzf3yoipv2q

3 August 2017

0 references

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fwrxp3ntezg3dbxpzf3yoipv2q

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMC publication ID

3568070

1 reference

3 August 2017

1 reference